WO2020013207A1 - 細胞培養用シート - Google Patents
細胞培養用シート Download PDFInfo
- Publication number
- WO2020013207A1 WO2020013207A1 PCT/JP2019/027228 JP2019027228W WO2020013207A1 WO 2020013207 A1 WO2020013207 A1 WO 2020013207A1 JP 2019027228 W JP2019027228 W JP 2019027228W WO 2020013207 A1 WO2020013207 A1 WO 2020013207A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- cell culture
- cells
- adhesive surface
- layer
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 122
- 230000004956 cell adhesive effect Effects 0.000 claims abstract description 66
- 238000000034 method Methods 0.000 claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- 238000010030 laminating Methods 0.000 claims abstract description 6
- 239000010410 layer Substances 0.000 claims description 62
- 230000001070 adhesive effect Effects 0.000 claims description 48
- 239000000853 adhesive Substances 0.000 claims description 46
- 229920001721 polyimide Polymers 0.000 claims description 44
- 239000011342 resin composition Substances 0.000 claims description 16
- 239000004642 Polyimide Substances 0.000 claims description 13
- 239000012790 adhesive layer Substances 0.000 claims description 11
- 238000012258 culturing Methods 0.000 claims description 11
- 229920003002 synthetic resin Polymers 0.000 claims description 8
- 239000000057 synthetic resin Substances 0.000 claims description 8
- 239000011148 porous material Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 abstract description 13
- 210000004027 cell Anatomy 0.000 description 160
- 239000000126 substance Substances 0.000 description 61
- 229920005575 poly(amic acid) Polymers 0.000 description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 229910052731 fluorine Inorganic materials 0.000 description 26
- 230000003068 static effect Effects 0.000 description 23
- 125000001153 fluoro group Chemical group F* 0.000 description 22
- 239000002609 medium Substances 0.000 description 22
- 239000000758 substrate Substances 0.000 description 21
- 239000009719 polyimide resin Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 17
- 238000010586 diagram Methods 0.000 description 15
- 230000002209 hydrophobic effect Effects 0.000 description 15
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 14
- 230000001747 exhibiting effect Effects 0.000 description 14
- 239000000463 material Substances 0.000 description 11
- 125000000962 organic group Chemical group 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 description 9
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- -1 Polydimethylsiloxane Polymers 0.000 description 9
- 230000021164 cell adhesion Effects 0.000 description 9
- 239000011347 resin Substances 0.000 description 9
- 229920005989 resin Polymers 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 125000002947 alkylene group Chemical group 0.000 description 7
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 150000008064 anhydrides Chemical class 0.000 description 6
- 239000007640 basal medium Substances 0.000 description 6
- 229910052801 chlorine Inorganic materials 0.000 description 6
- 125000001309 chloro group Chemical group Cl* 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 238000000691 measurement method Methods 0.000 description 6
- 239000012299 nitrogen atmosphere Substances 0.000 description 6
- 210000000130 stem cell Anatomy 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- NVKGJHAQGWCWDI-UHFFFAOYSA-N 4-[4-amino-2-(trifluoromethyl)phenyl]-3-(trifluoromethyl)aniline Chemical compound FC(F)(F)C1=CC(N)=CC=C1C1=CC=C(N)C=C1C(F)(F)F NVKGJHAQGWCWDI-UHFFFAOYSA-N 0.000 description 5
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 5
- 125000000732 arylene group Chemical group 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000010304 firing Methods 0.000 description 5
- 239000011737 fluorine Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000003075 superhydrophobic effect Effects 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 150000004985 diamines Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- XUSNPFGLKGCWGN-UHFFFAOYSA-N 3-[4-(3-aminopropyl)piperazin-1-yl]propan-1-amine Chemical compound NCCCN1CCN(CCCN)CC1 XUSNPFGLKGCWGN-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920002799 BoPET Polymers 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000007112 amidation reaction Methods 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 3
- BIEJPBBEABOGMM-UHFFFAOYSA-N 2-[4-(2-aminophenoxy)phenoxy]aniline Chemical compound NC1=CC=CC=C1OC(C=C1)=CC=C1OC1=CC=CC=C1N BIEJPBBEABOGMM-UHFFFAOYSA-N 0.000 description 2
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 2
- KMKWGXGSGPYISJ-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]propan-2-yl]phenoxy]aniline Chemical compound C=1C=C(OC=2C=CC(N)=CC=2)C=CC=1C(C)(C)C(C=C1)=CC=C1OC1=CC=C(N)C=C1 KMKWGXGSGPYISJ-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920001342 Bakelite® Polymers 0.000 description 2
- 229920002943 EPDM rubber Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000043261 Hevea brasiliensis Species 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 108010076089 accutase Proteins 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000004637 bakelite Substances 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 239000012973 diazabicyclooctane Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000003475 lamination Methods 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- VGIVLIHKENZQHQ-UHFFFAOYSA-N n,n,n',n'-tetramethylmethanediamine Chemical compound CN(C)CN(C)C VGIVLIHKENZQHQ-UHFFFAOYSA-N 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 1
- CJAOGUFAAWZWNI-UHFFFAOYSA-N 1-n,1-n,4-n,4-n-tetramethylbenzene-1,4-diamine Chemical compound CN(C)C1=CC=C(N(C)C)C=C1 CJAOGUFAAWZWNI-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 1
- HHLMWQDRYZAENA-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]-1,1,1,3,3,3-hexafluoropropan-2-yl]phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=C(C(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)(C(F)(F)F)C(F)(F)F)C=C1 HHLMWQDRYZAENA-UHFFFAOYSA-N 0.000 description 1
- HYDATEKARGDBKU-UHFFFAOYSA-N 4-[4-[4-(4-aminophenoxy)phenyl]phenoxy]aniline Chemical group C1=CC(N)=CC=C1OC1=CC=C(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)C=C1 HYDATEKARGDBKU-UHFFFAOYSA-N 0.000 description 1
- VQVIHDPBMFABCQ-UHFFFAOYSA-N 5-(1,3-dioxo-2-benzofuran-5-carbonyl)-2-benzofuran-1,3-dione Chemical compound C1=C2C(=O)OC(=O)C2=CC(C(C=2C=C3C(=O)OC(=O)C3=CC=2)=O)=C1 VQVIHDPBMFABCQ-UHFFFAOYSA-N 0.000 description 1
- QQGYZOYWNCKGEK-UHFFFAOYSA-N 5-[(1,3-dioxo-2-benzofuran-5-yl)oxy]-2-benzofuran-1,3-dione Chemical compound C1=C2C(=O)OC(=O)C2=CC(OC=2C=C3C(=O)OC(C3=CC=2)=O)=C1 QQGYZOYWNCKGEK-UHFFFAOYSA-N 0.000 description 1
- JVERADGGGBYHNP-UHFFFAOYSA-N 5-phenylbenzene-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C(C(=O)O)=CC(C=2C=CC=CC=2)=C1C(O)=O JVERADGGGBYHNP-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- VZUHQRBBQSLSHS-SSZFMOIBSA-N Isoimide Chemical compound C1=CC(Br)=CC=C1\N=C/1C(CCCC2)=C2C(=O)O\1 VZUHQRBBQSLSHS-SSZFMOIBSA-N 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000004049 embossing Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000006358 imidation reaction Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- LSACYLWPPQLVSM-UHFFFAOYSA-N isobutyric acid anhydride Chemical compound CC(C)C(=O)OC(=O)C(C)C LSACYLWPPQLVSM-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- DIHKMUNUGQVFES-UHFFFAOYSA-N n,n,n',n'-tetraethylethane-1,2-diamine Chemical compound CCN(CC)CCN(CC)CC DIHKMUNUGQVFES-UHFFFAOYSA-N 0.000 description 1
- UNEXJVCWJSHFNN-UHFFFAOYSA-N n,n,n',n'-tetraethylmethanediamine Chemical compound CCN(CC)CN(CC)CC UNEXJVCWJSHFNN-UHFFFAOYSA-N 0.000 description 1
- TXXWBTOATXBWDR-UHFFFAOYSA-N n,n,n',n'-tetramethylhexane-1,6-diamine Chemical compound CN(C)CCCCCCN(C)C TXXWBTOATXBWDR-UHFFFAOYSA-N 0.000 description 1
- DMQSHEKGGUOYJS-UHFFFAOYSA-N n,n,n',n'-tetramethylpropane-1,3-diamine Chemical compound CN(C)CCCN(C)C DMQSHEKGGUOYJS-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical compound NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001643 poly(ether ketone) Polymers 0.000 description 1
- 229920003050 poly-cycloolefin Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000001988 somatic stem cell Anatomy 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- JABYJIQOLGWMQW-UHFFFAOYSA-N undec-4-ene Chemical compound CCCCCCC=CCCC JABYJIQOLGWMQW-UHFFFAOYSA-N 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/06—Plates; Walls; Drawers; Multilayer plates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/04—Flat or tray type, drawers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/12—Well or multiwell plates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/20—Material Coatings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0062—General methods for three-dimensional culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2535/00—Supports or coatings for cell culture characterised by topography
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2535/00—Supports or coatings for cell culture characterised by topography
- C12N2535/10—Patterned coating
Definitions
- the present invention relates to a cell culture sheet. More specifically, the present invention relates to a cell culture sheet and a method for producing the same, a cell culture instrument including the sheet, and a method for producing a spheroid using the sheet or the instrument.
- Patent Document 1 in a microchip having a plurality of cell holding cavities, an adhesive region in which a bottom surface of the cavity exhibits cell adhesiveness, and a non-adhesive region surrounding the adhesive region and exhibiting cell non-adhesiveness It is described that by including the above, a cell tissue body having a uniform shape and size can be formed.
- Patent Document 2 discloses a method for culturing cells on a porous film having through-holes. The surface of the porous film is composed of a cell-adhesive region and a cell-non-adhesive region, A method for efficiently culturing a three-dimensional tissue body while smoothly supplying a culture solution and discharging waste products is disclosed.
- An object of the present invention is to provide a novel cell culture sheet.
- the present invention provides a sheet for cell culture and a method for producing the same, a cell culture instrument including the sheet, and the sheet or instrument, which can be easily prepared and can efficiently perform cell culture.
- An object of the present invention is to provide a method for producing spheroids using spheroids.
- the present inventors have conducted intensive studies to achieve the above object, and as a result, by forming a cell culture surface on a specific surface, not only the preparation of a cell culture sheet is simplified, but also such as medium exchange and cell seeding.
- the present inventors have found that the work of cell culture itself has been facilitated, and that the uniformity of the obtained cell aggregates (spheroids) has been improved, thereby completing the present invention.
- the present invention relates to the following [1] to [10].
- [1] For cell culture, having a plurality of recesses having an opening having a pore diameter of 1000 ⁇ m or less, an inner surface of the recess having a cell non-adhesive surface, and a bottom surface of the recess having a cell adhesive surface.
- Sheet. [2] The cell culture sheet according to the above [1], which is a laminate of a layer having a cell non-adhesive surface having a through-hole and a layer having a cell adhesive surface. [3] The cell culture sheet according to [2], further including an adhesive layer between the layer having a cell non-adhesive surface and the layer having a cell adhesive surface.
- a method for producing a sheet for cell culture comprising laminating a layer having a cell non-adhesive surface having a plurality of through holes having a diameter of 1000 ⁇ m or less and a layer having a cell adhesive surface.
- a cell culture instrument comprising the cell culture sheet according to any one of [1] to [7].
- a method for culturing spheroids comprising culturing with the cell culture sheet or cell culture device according to any of [1] to [7] and [9].
- the cell culture sheet of the present invention can be easily prepared, and the cell culture operation itself can be performed efficiently.
- the uniformity of the obtained cell aggregates can be improved, and the excellent effect of facilitating the quality control of cells can be achieved.
- FIG. 1 is a diagram schematically showing a sheet cross-sectional structure of one embodiment of the cell culture sheet of the present invention.
- FIG. 2 is a diagram schematically showing a sheet cross-sectional structure of one embodiment of the cell culture sheet of the present invention.
- FIG. 3 is a diagram schematically showing a sheet cross-sectional structure of one embodiment of the cell culture sheet of the present invention.
- FIG. 4 is a diagram schematically showing one embodiment in which cells are cultured in the cell culture sheet of the present invention.
- FIG. 5 is a diagram schematically showing one embodiment in which cells are cultured in the cell culture sheet of the present invention.
- FIG. 6 is a diagram schematically showing a sheet cross-sectional structure of one embodiment of the cell culture sheet of the present invention.
- FIG. 7 is a view showing a photograph of a spheroid obtained using the cell culture sheet of the present invention.
- FIG. 8 is a diagram showing the fluid diameter of spheroids obtained using the cell culture sheet of the present invention.
- FIG. 9 is a view showing the circle equivalent diameter of spheroids obtained using the cell culture sheet of the present invention.
- FIG. 10 is a diagram showing the circularity of spheroids obtained using the cell culture sheet of the present invention.
- FIG. 11 is a diagram showing the division of the cell culture sheet used in Test Examples 2 and 3.
- FIG. 12 is a diagram showing a circle-equivalent diameter at each point of a spheroid obtained by using the cell culture sheet of the present invention.
- FIG. 13 is a diagram showing a circle-equivalent diameter of each spheroid obtained by using the cell culture sheet of the present invention.
- FIG. 14 is a diagram showing photographs of spheroids obtained using the cell culture sheets of Examples 2 to 5.
- the cell culture sheet of the present invention has a plurality of recesses having an opening having a diameter of 1000 ⁇ m or less, an inner surface of the recess has a cell non-adhesive surface, and a bottom surface of the recess has a cell adhesive surface. Having.
- the structure of the cell culture sheet of the present invention will be described with reference to an example of a cross-sectional view of the sheet cut in a direction perpendicular to the recess.
- a plurality of recesses 11 are present on a sheet surface 12, and the recesses 11 are constituted by an inner surface 11 a and a bottom surface 11 b, and form a cell tissue (spheroid) in the recesses 11.
- the sheet for cell culture of the present invention has a plurality of concave portions on the sheet surface.
- a plurality of recesses 11 exist on the sheet surface 12.
- the number of the concave portions cannot be unconditionally set according to the sheet area, the type of cells to be cultured, and the like, and can be appropriately set according to the common general knowledge in the art.
- the lower limit number per unit area (cm 2 ) may be one, but 10, 20, 30, 50, etc. can be exemplified, and the upper limit number is 1,000, 500, 300, 200. , 100, and the like.
- the total number of concave portions on the sheet surface can be set as appropriate, for example, 10 or more, 100 or more, 1000 or more, 10,000 or more, 50,000 or more.
- the shape of the opening of the recess is not limited to a circle, but may be, for example, a polygon or an ellipse.
- the diameter of the opening may be 1000 ⁇ m or less, and can be appropriately set according to the common technical knowledge in the art depending on the size of the cells to be cultured.
- the aperture is the diameter (maximum length) of a circle formed so as to include the target location, regardless of the shape of the target location, and the aperture of the opening is, for example, In 1, the length is indicated by D (11).
- Examples of the diameter of the opening include a range of 10 to 1000 ⁇ m, 10 to 700 ⁇ m, 10 to 600 ⁇ m, and 10 to 500 ⁇ m.
- the shape of the bottom surface of the concave portion is not limited to a circle, and may be, for example, a polygon or an ellipse, and may be the same as or different from the shape of the opening.
- the diameter (length) of the bottom surface may be the same as or different from the diameter of the opening, and even if the diameter of the bottom surface is smaller than the diameter of the opening, the diameter of the bottom surface may be smaller than that of the opening.
- the diameter may be larger than the diameter.
- the diameter of the bottom is, for example, the length indicated by DB (11b) in FIG.
- the diameter of the bottom is, for example, 10 to 1000 ⁇ m, 10 to 700 ⁇ m, 10 to 600 ⁇ m, 10 to 500 ⁇ m, Examples are in the range of 10 to 400 ⁇ m and 10 to 300 ⁇ m.
- the shape of the concave portion is a tapered shape facing the bottom surface side of the concave portion.
- the ratio of the diameter of the bottom to the diameter of the opening is not particularly limited, but from the viewpoint of ease of seeding and recovery of cells, from 5/1 to 1 / 5, 3/1 to 1/3 and 1/1 to 1/2 are exemplified.
- the distance (gap) between the opening and the adjacent opening is, for example, the length indicated by D (12) in FIG. 1 and is not particularly limited, but is desired. Depending on the cell culture, for example, the range is 800 ⁇ m or less, 700 ⁇ m or less, 600 ⁇ m or less, 500 ⁇ m or less, 300 ⁇ m or less, 200 ⁇ m or less, 100 ⁇ m or less, and any finite value may be used.
- the depth of the concave portion can be appropriately set according to the common general knowledge in the art depending on the size of the cell to be cultured.
- the depth of the concave portion is, for example, a length indicated by D (11a) in FIG. 1, and is, for example, in the range of 10 to 300 ⁇ m or 10 to 1000 ⁇ m.
- the ratio of the diameter of the opening to the depth of the recess is not particularly limited, but from the viewpoint of ease of cell seeding and collection, from 5/1 to 5/1. Examples are 1/5, 3/1 to 1/3, and 2/1 to 1/2. When the content is within the above range, the cells are less likely to jump out of the concave portions, and operations such as cell collection and defoaming are facilitated.
- the thickness of the bottom surface of the concave portion is not particularly limited, and can be appropriately set according to the common technical knowledge.
- the recess has a cell non-adhesive surface on the inner surface and a cell adhesive surface on the bottom surface. With such a configuration, it is possible to improve the uniformity of the obtained cell tissue.
- the inner surface 11a has a cell non-adhesive surface and the bottom surface 11b has a cell adhesive surface.
- a cell non-adhesive surface is, for example, in a solution used for culture, when cells settle on the surface, the cells hardly change their shape, do not adhere at all, or are temporarily weak.
- Such a surface may be, for example, any substance formed by physically or chemically fixing a substance exhibiting cell non-adhesiveness to the surface of the substrate constituting the concave portion, and the substrate itself exhibits cell non-adhesiveness. It may be made of a substance. For example, when a substance showing cell non-adhesion is fixed to the surface, as shown in the schematic diagram of FIG. 2, a substance 21 showing cell non-adhesion is fixed on the sheet surface 12 and the inner side surface 11a of the concave portion 11. Have been.
- the substance showing cell non-adhesion is not particularly limited as long as it is a substance that does not adhere to cells used for culture or does not bind to cell surface molecules such as proteins and sugar chains present in the cell membrane of the cells used. It may or may not have biocompatibility. Further, it may be hydrophobic or hydrophilic, and for example, may be super-hydrophobic (super-hydrophobic) or super-hydrophilic.
- a hydrophobic (particularly superhydrophobic) for example, a hydrophobic or hydrophilic (particularly hydrophobic) cell-adhesive surface or constituting the surface Substances exhibiting more hydrophobicity (especially superhydrophobicity) with respect to the resin (and further the contact angle thereof)] are particularly preferable, but are preferably hydrophilic (especially superhydrophilic) [eg, hydrophilic or hydrophobic (eg, hydrophobic). )), which is more hydrophilic (particularly, super-hydrophilic) with respect to the cell-adhesive surface or the resin constituting the surface (and the contact angle thereof).
- Such substances include polyethylene glycol and its derivatives, MPC (2-methacryloyloxyethyl phosphorylcholine), poly-HEMA (polyhydroxyethyl methacrylate), and compounds such as SPC (segmented polyurethane), and obtained from living organisms.
- the obtained protein (such as albumin) can be appropriately selected and used according to the type of cell. Among them, from the viewpoint of adhesion to the synthetic resin used as the base material, or from the viewpoint of simplifying the manufacturing process of the cell culture sheet, or from the viewpoint of improving the uniformity of the obtained cell tissue, MPC, etc. (2-methacryloyloxyethyl phosphorylcholine) is preferred.
- the substance may be appropriately modified depending on the handling property, the degree of desired hydrophobicity (for example, superhydrophobicity) and hydrophilicity (for example, superhydrophilicity).
- a hydrophilic substance and low solubility in water may be made compatible by subjecting a hydrophilic substance to a crosslinking treatment or the like.
- the raw material for example, hydrophobic or hydrophilic
- a hydrophilic treatment for example, introduction of a hydrophobic group or a hydrophilic group
- Material may be obtained.
- the immobilization of the substance exhibiting cell non-adhesion is carried out by drying a solution containing these substances on the surface of the substrate, melting and pressing the substance, and applying the substance applied to the substrate to an energy ray such as UV rays.
- a covalent bond by causing a chemical reaction (for example, a condensation reaction between functional groups such as a carboxyl group or an amino group) between the functional group of the substance and the functional group on the substrate. It can be immobilized on the surface of the substrate by a method of bonding the thiol group of the substance or a metal (platinum, gold, etc.) film formed on the substrate in advance.
- the thickness at the time of immobilization is not particularly limited, and is, for example, 0.01 to 1000 ⁇ m.
- the ratio of the surface showing cell non-adhesiveness occupying the inner side surface of the concave portion is not particularly limited, but it is preferable that the ratio reduces the adherence of cultured cells. Preferably, it occupies 90% or more, more preferably 95% or more, particularly preferably all of the area of the inner surface.
- the surface showing cell non-adhesiveness from the viewpoint of uniformizing the size of the formed cell tissue or improving the circularity, as its surface characteristics, for example, to determine the static water contact angle described later as an index Can be.
- the static water contact angle is preferably 90 ° or more, more preferably 93 ° or more, and further preferably 95 ° or more. Further, it may be 150 ° or less, preferably 130 ° or less, more preferably 120 ° or less.
- the static water contact angle is preferably 65 ° or less, more preferably 55 ° or less, and further preferably 50 ° or less.
- the static water contact angle can achieve a static water contact angle of, for example, 90 ° or more, 100 ° or more.
- a static water contact angle may be a value on a cell non-adhesive surface, or may be a value on a substance showing cell non-adhesion (or a substance constituting a cell non-adhesive surface). Good.
- the static water contact angle may be measured, for example, by a method described later.
- the cell-adhesive surface means that, for example, when cells settle on the surface in a solution used for culturing, the cells adhere with a certain adhesion point.
- it refers to a surface that is adhered so as to be fixed to such an extent that it can be peeled off by a liquid flow such as pipetting.
- a surface that adheres to such an extent that a three-dimensional or three-dimensional tissue such as a layer or spheroid can be formed. Can be mentioned.
- Such a surface may be, for example, any material formed by physically or chemically fixing or arranging a substance exhibiting cell adhesion on the surface of the base material constituting the bottom surface of the concave portion.
- the base material itself may be made of a substance exhibiting cell adhesion, even if it is arranged other than in the recess.
- the region including the bottom surface 11b of the recess 11 is formed of a layer made of the substance 22 exhibiting cell adhesion. Is also good.
- the substance exhibiting cell adhesion is not particularly limited as long as it is a substance that can be adhered to cells used for culture or can bind to cell surface molecules such as proteins and sugar chains present in the cell membrane of the cells used.
- the degree of adhesiveness of the substance exhibiting cell adhesiveness may be such that the cells do not protrude from the inside of the recess.
- Such substances include substances obtained or synthesized from living organisms, such as proteins (collagen, fibronectin, laminin, etc.) and synthetic resins (fluororesins, polyimide resins, polysulfones, polyethersulfones). , Polydimethylsiloxane, mixtures thereof, etc.).
- synthetic resins fluororesins, polyimide resins, polysulfones, polyethersulfones). , Polydimethylsiloxane, mixtures thereof, etc.
- a synthetic resin such as a polyimide resin.
- a non-living component such as a polyimide resin
- the cell tissue (spheroid) obtained by the cell culture sheet of the present invention containing the polyimide resin can be applied to fields such as regenerative medicine and drug discovery. It will be easier.
- the polyimide resin examples include a polyimide resin containing a structural unit represented by the following formula (I).
- a resin having a fluorine atom in the molecule is preferable, and a fluorine-containing polyimide (fluorine-containing polyimide resin) is more preferable.
- the polyimide resin used in the present invention is typically obtained by imidizing a polyamic acid obtained by polymerizing at least one kind of each of an acid dianhydride and a diamine.
- the polyimide resin may include polyamic acid as a part of the chemical structure.
- a method for producing the polyimide resin a known method may be used.
- a two-stage synthesis method can be used.
- the two-step synthesis method of a polyimide resin is a method of synthesizing a polyamic acid as a precursor and converting the polyamic acid into a polyimide acid.
- the polyamic acid as the precursor may be a polyamic acid derivative.
- the polyamic acid derivative include a polyamic acid salt, a polyamic acid alkyl ester, a polyamic acid amide, a polyamic acid derivative derived from bismethylidene pyromellitide, a polyamic acid silyl ester, and a polyamic acid isoimide.
- polyimide As polyimide, pyromellitic dianhydride, biphenyltetracarboxylic dianhydride, acid anhydrides such as benzophenonetetracarboxylic dianhydride, and diamines such as oxydiamine, paraphenylenediamine, metaphenylenediamine, and benzophenonediamine Can be exemplified.
- Examples of the resin having a fluorine atom include 4,4′-hexafluoroisopropylidene diphthalic anhydride (6FDA) / 1,4-bis (aminophenoxy) benzene (TPEQ) copolymer and 6FDA / 4,4 '-Oxydiphthalic anhydride (ODPA) / TPEQ copolymer, 4,4'-(4,4'-isopropylidenediphenoxy) diphthalic acid (BPADA) / 2,2-bis [4- (4-aminophenoxy ) Phenyl] hexafluoropropane (HFBAPP), 6FDA / 2,2-bis (4- (4-aminophenoxy) phenyl) propane (BAPP) copolymer, 6FDA / 2,2′-bis (trifluoromethyl) benzidine (TFMB) copolymer, 6FDA / 4,4′-diaminodiphenyl ether (ODA) copolymer,
- X 0 represents any one of an oxygen atom, a sulfur atom, and a divalent organic group
- Y represents a divalent organic group
- Z 1 , Z 2 , Z 3 , Z 4 , Z 5 , and Z 6 each independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom or an iodine atom
- p is 0 or 1.
- the chemical structure represented by the formula (I) may be different for each structural unit of the resin, or may be the same. It is preferable that at least one of X 0 , Y, Z 1 , Z 2 , Z 3 , Z 4 , Z 5 , and Z 6 contains one or more fluorine atoms.
- divalent organic group represented by X 0 examples include an alkylene group, an arylene group, an aryleneoxy group, an arylenethio group, and the like.
- an alkylene group, an aryleneoxy group, an arylenethio group Are preferable, and an alkylene group and an aryleneoxy group are more preferable, and these may be substituted with a fluorine atom.
- the alkylene group has, for example, 1 to 12, and preferably 1 to 6, carbon atoms.
- Examples of the alkylene group substituted with a fluorine atom, which is an example of X 0 include -C (CF 3 ) 2- , -C (CF 3 ) 2 -C (CF 3 ) 2- and the like. .
- alkylene groups which are examples of X 0 , —C (CF 3 ) 2 — is preferred.
- Examples of the arylene group that is an example of X 0 include the following.
- Examples of the aryleneoxy group which is an example of X 0 include the following.
- Examples of the arylenethio group which is an example of X 0 include the following.
- the divalent organic group represented by X 0 is selected from the group consisting of b-2 to b-10 and c-2 to c-10. It is more preferably selected from the group consisting of b-7 to b-9 and c-7 to c-9, and more preferably the structure represented by b-8.
- the divalent organic group represented by X 0 is preferably —C (CF 3 ) 2 —.
- arylene group, aryleneoxy group and arylenethio group which are examples of X 0 are each independently a halogen atom (for example, a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, preferably a fluorine atom or a chlorine atom. And more preferably a fluorine atom), a methyl group and a trifluoromethyl group.
- halogen atom for example, a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, preferably a fluorine atom or a chlorine atom. And more preferably a fluorine atom
- substituents may be plural, and in that case, the types of the substituents may be the same or different from each other.
- Preferred substituents on the arylene group, aryleneoxy group and arylenethio group are a fluorine atom and / or a trifluoromethyl group, preferably a fluorine atom.
- Y is substituted with at least one fluorine atom.
- the divalent organic group represented by Y is not particularly limited, and examples thereof include a divalent organic group having an aromatic ring. Specifically, a group consisting of one benzene ring or a group having a structure in which two or more benzene rings are bonded via a carbon atom (that is, a single bond or an alkylene group), an oxygen atom, a sulfur atom or directly. No. Specifically, the following groups can be exemplified.
- the above-mentioned divalent organic group having an aromatic ring as an example of Y is a halogen atom (for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, and preferably a fluorine atom or a chlorine atom, if it can be substituted. , More preferably a fluorine atom), a methyl group and a trifluoromethyl group.
- halogen atom for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, and preferably a fluorine atom or a chlorine atom, if it can be substituted.
- More preferably a fluorine atom a methyl group and a trifluoromethyl group.
- a preferable substituent substituted on the divalent organic group having an aromatic ring is preferably a fluorine atom and / or a trifluoromethyl group, particularly when X 0 does not contain a fluorine atom, and more preferably. Is a fluorine atom.
- Y is a structure selected from the group consisting of d-3, d-9, e-1 to e-4, f-6, and f-7.
- the structure is more preferably e-1, e-3 or e-4.
- Z 1 , Z 2 , Z 3 , Z 4 , Z 5 , and Z 6 may be the same or different, and each independently represents a hydrogen atom, a fluorine atom , A chlorine atom, a bromine atom or an iodine atom, and when at least one of X 0 and Y contains no fluorine atom, at least one of Z 1 , Z 2 , Z 3 , Z 4 , Z 5 , and Z 6 One is preferably a fluorine atom.
- the divalent organic group represented by X 0 is —C (CF 3 ) 2 —, b-2 to b -10 and c-2 to c-10; and Y is selected from the group consisting of d-3, d-9, e-1 to e-4, f-6, and f-7. Selected.
- the divalent organic group represented by X 0 is —C (CF 3 ) 2 —, b-7 to b-9 and c-7 to selected from the group consisting of c-9; and Y is selected from the group consisting of e-1, e-3 and e-4.
- the polyimide resin comprising the structural unit represented by the above formula (I) can be obtained by a method of firing a polyamic acid obtained by polymerization of an acid dianhydride and a diamine.
- the imidation ratio of the “polyimide resin comprising the structural unit represented by the formula (I)” need not be 100%. That is, the polyimide resin composed of the structural unit represented by the formula (I) may be composed of only the structural unit represented by the above formula (I), provided that the effects of the present invention are not impaired.
- a structural unit in which the cyclic imide structure remains an amic acid without dehydration ring closure may be partially contained.
- the polyamic acid synthesis reaction is preferably performed in an organic solvent.
- the organic solvent used for the polyamic acid synthesis reaction is not particularly limited as long as the reaction between the acid dianhydride and the diamine as the raw materials can efficiently proceed and is inert to these raw materials. .
- N-methylpyrrolidone N, N-dimethylacetamide, N, N-dimethylformamide, tetrahydrofuran, dimethyl sulfoxide, sulfolane, methyl isobutyl ketone, acetonitrile, benzonitrile, nitrobenzene, nitromethane, acetone, methyl ethyl ketone, isobutyl ketone
- polar solvents such as methanol and the like; non-polar solvents such as toluene and xylene. Especially, it is preferable to use a polar solvent.
- These organic solvents may be used alone or as a mixture of two or more.
- the reaction mixture after the amidation reaction may be directly subjected to thermal imidization.
- concentration of the polyamic acid in the polyamic acid solution is not particularly limited, but from the polymerization reactivity of the obtained resin composition and the viscosity after polymerization, subsequent film formation, ease of handling in firing, preferably 5 % By weight, more preferably 10% by weight or more, preferably 50% by weight or less, more preferably 40% by weight or less.
- the polyamic acid is imidized by either thermal imidization or chemical imidization to obtain a resin composition containing a fluorinated polyimide.
- the polyamic acid is imidized (thermally imidized) by a heat treatment to obtain a resin composition containing a fluorinated polyimide.
- the polyimide obtained by thermal imidization has no possibility of remaining catalyst, and is more preferable for cell culture use.
- the above-mentioned polyamic acid is converted into air, or more preferably under an atmosphere of an inert gas such as nitrogen, helium or argon, or under vacuum, preferably at a temperature of 50 to 400 ° C.
- the resin composition containing polyimide is obtained by baking at 100 to 380 ° C., preferably for 0.1 to 10 hours, more preferably for 0.2 to 5 hours, and performing an imidization reaction. be able to.
- the polyamic acid to be subjected to the thermal imidization reaction is preferably in a form dissolved in a suitable solvent. Any solvent may be used as long as it can dissolve the polyamic acid, and the above-mentioned solvent for the polyamic acid synthesis reaction can also be used.
- the polyamic acid can be directly imidized by using a dehydration cyclization reagent described below in an appropriate solvent.
- the dehydration cyclization reagent can be used without any particular limitation as long as it has a function of chemically dehydrating and cyclizing a polyamic acid into a polyimide.
- a dehydration cyclization reagent the use of a tertiary amine compound alone or a combination of a tertiary amine compound and a carboxylic anhydride can promote imidization efficiently. Is preferred.
- tertiary amine compound examples include trimethylamine, triethylamine, tripropylamine, tributylamine, pyridine, 1,4-diazabicyclo [2.2.2] octane (DABCO), and 1,8-diazabicyclo [5.4.
- pyridine, DABCO, N, N, N ', N'-tetramethyldiaminomethane are preferred, and DABCO is more preferred.
- the tertiary amine may be only one kind or two or more kinds.
- carboxylic anhydride examples include acetic anhydride, trifluoroacetic anhydride, propionic anhydride, butyric anhydride, isobutyric anhydride, succinic anhydride, and maleic anhydride.
- acetic anhydride and trifluoroacetic anhydride are particularly preferred, and acetic anhydride is more preferred.
- the carboxylic anhydride may be used alone or in combination of two or more.
- a polar solvent having excellent solubility is preferable.
- tetrahydrofuran, N, N-dimethylacetamide, N, N-dimethylformamide, N-methylpyrrolidone, dimethylsulfoxide and the like can be mentioned.
- N, N-dimethylacetamide, N, N-dimethylformamide and N It is preferable that at least one selected from the group consisting of -methylpyrrolidone is used from the viewpoint of performing a homogeneous reaction.
- these solvents are used as the solvent for the amidation reaction, the polyamic acid can be used as it is for the chemical imidization without separation from the reaction mixture after the amidation reaction.
- the weight average molecular weight of the polyimide resin is, for example, 5,000 to 2,000,000, preferably 8,000 to 1,000,000, and more preferably 20,000 to 500,000.
- the weight average molecular weight of a resin is a value measured by the following method. When the weight average molecular weight is in the above range, the synthesis and handling of the polyimide resin, the formation of a film, and the spheroid-forming property are further improved.
- the cell-adhesive substance or cell-adhesive surface [hydrophobic (particularly non-superhydrophobic) cell-adhesive substance or cell-adhesive surface] preferably has a static water contact angle of 70 ° or more.
- the falling angle may be 15 ° or more, and the static water contact angle may be 70 ° or more and the falling angle may be 15 ° or more.
- the static water contact angle is more preferably 75 ° or more (for example, more than 75 °), further preferably 77 ° or more, more preferably 79 ° or more, and more preferably It is more preferably 80 ° or more (eg, more than 80 °), and the upper limit of the static water contact angle is, for example, less than 150 °, preferably 120 ° or less (eg, less than 120 °), more preferably The temperature is 110 ° or less, and more preferably 100 ° C or less (eg, less than 99 ° C, 98 ° C or less, 97 ° C or less, 95 ° C or less).
- the cell-adhesive substance or cell-adhesive surface [hydrophilic (particularly, non-superhydrophilic) cell-adhesive substance or surface] has a static water contact angle of 65 ° or less, more preferably 55 ° or less. ° or less, more preferably 50 ° or less.
- the lower limit may be 0 ° or more, preferably 5 ° or more, and more preferably 10 ° or more.
- the falling angle is preferably higher in the order of 18 ° or more, 19 ° or more, 20 ° or more, 22 ° or more, 24 ° or more, 26 ° or more, 28 ° or more, 30 ° or more.
- the upper limit of the falling angle is, for example, less than 80 °, preferably 70 ° or less (eg, less than 70 °), more preferably 60 ° or less (eg, less than 60 °), and further preferably 50 °.
- the following for example, less than 50 °.
- the static water contact angle and the falling angle may be values measured by the following method.
- Apparatus Automatic contact angle meter (DM-500, manufactured by Kyowa Interface Science) Measuring method: Measure the adhesion angle of the droplet immediately after dropping 2 ⁇ L of water on the surface (cell-non-adhesive surface or cell-adhesive surface) or film (film formed of non-cell-adhesive or cell-adhesive substance) (Measurement temperature: 25 ° C.).
- Apparatus Automatic contact angle meter (DM-500, manufactured by Kyowa Interface Science) Measurement method: After dropping 25 ⁇ L of water on the surface (non-cell-adhesive surface or cell-adhesive surface) or film (film formed of non-cell-adhesive or cell-adhesive substance), continuously tilt the substrate The falling angle is defined as the falling angle (measuring temperature: 25 ° C.).
- the difference in static water contact angle between the cell-adhesive surface (or cell-adhesive substance) and the cell non-adhesive surface (or cell-non-adhesive substance) is preferably 3 ° or more (eg, 5 ° or more), more preferably 10 ° or more (eg, 12 ° or more), and even more preferably 15 ° or more.
- the upper limit can be appropriately selected according to the combination of hydrophobicity and hydrophilicity of the cell non-adhesive substance (surface) and the cell adhesive substance (surface), and is not particularly limited. For example, 100 °, 90 °, It may be 80 °, 70 °, 60 °, 50 °, 40 °, 30 ° or the like.
- the resin constituting the cell adhesive surface may further contain additive components such as a plasticizer and an antioxidant.
- the ratio of the surface exhibiting cell adhesion to the bottom surface of the concave portion is not particularly limited, but may be 90% or more, 95% or more, 99% or more, and substantially all of the bottom surface of the concave portion. preferable.
- the sheet surface which is also the peripheral portion of the recesses, has a cell non-adhesive surface from the viewpoint of simplifying the production of the cell culture sheet.
- a cell non-adhesive surface of the sheet surface may be the same cell non-adhesive surface as the inner surface of the concave portion or a different cell non-adhesive surface.
- the sheet surface and the inner surface of the recess have a continuous surface.
- the ratio of the surface showing cell non-adhesiveness to the surface of the sheet which is also the edge of the concave portion is not particularly limited, but is 90% or more, 95% or more, 99% or more of the edge portion of the concave portion. Preferably, it occupies substantially all of the periphery.
- the surface showing cell non-adhesiveness is not particularly limited as a percentage of the sum of the edge of the recess and the inner surface of the recess, but is not particularly limited, but of the total of the edge of the recess and the inner surface of the recess, Preferably, it occupies 90% or more, 95% or more, 99% or more, and substantially all of the peripheral portion and the inner surface.
- FIGS. 4 and 5 schematically show a cell culture state in the concave portion of the cell culture sheet of the present invention.
- the sheet for cell culture of the present invention has a plurality of the above-mentioned concave structures
- FIG. 4 and FIG. 5 show that the sheet may be a layered structure including a layer including the bottom surface of the concave portion and a layer including the inner side surface of the concave portion. I can say.
- the layer including the inner side surface of the concave portion itself constitutes a layer having a through hole. Therefore, as one embodiment of the cell culture sheet of the present invention, there can be mentioned an embodiment which is a laminate of a layer having a cell non-adhesive surface having through holes and a layer having a cell adhesive surface.
- the layer having a cell non-adhesive surface may be a layer having a cell non-adhesive substance immobilized on a layered substrate or a layer made of a cell non-adhesive substance.
- a material in which a substance having cell non-adhesiveness is immobilized on a layered substrate is preferable.
- the production of the cell culture sheet becomes simpler, and further, for example, by forming a through-hole or a concave portion in the base material and then fixing a substance showing cell non-adhesiveness, etc. Since it is possible to prevent the cell non-adhesive surface from being damaged by the formation of the concave portion, it is preferable from the viewpoint of improving the cell culture characteristics of the cell culture sheet.
- any one known in the art can be used.
- polystyrene polyethylene, polypropylene, polycarbonate, polyamide, polyacetal, polyester (eg, polyethylene terephthalate), polyurethane, polysulfone, polyacrylate, polymethacrylate, polyvinyl, polycycloolefin, polyetherketone, polyetheretherketone, polyimide, silicon, etc.
- a synthetic resin such as EPDM (Ethylene Propylene Diene Monomer), a natural rubber, a plate-shaped body made of a metal material such as glass, ceramic, stainless steel, or the like.
- a transparent substrate is also one of the preferred embodiments.
- the immobilization of the substance showing cell non-adhesiveness to the layered substrate can be performed in the same manner as the method of immobilizing the substance showing cell non-adhesiveness on the inner surface of the concave portion.
- the layer having a cell non-adhesive surface preferably includes the sheet surface and the through holes of the cell culture sheet of the present invention.
- the through-hole preferably has a wall corresponding to the inner side surface of the above-described concave portion, and the hole diameter and shape of the opening and the opposite end can be set in the same manner as the above-described concave portion.
- the depth of the through hole corresponds to the thickness of the layer having the cell non-adhesive surface, but also corresponds to the depth of the above-described concave portion, and can be set in the same manner as the concave portion.
- a layer of the substance showing cell non-adhesion for example, preferably 1 nm or more, more preferably 10 nm or more
- the thickness can be appropriately set as long as the thickness of the entire layer including the layer of the substance exhibiting cell non-adhesiveness and the substrate is within the range of the thickness of the layer having the cell non-adhesive surface.
- the formation of the through-hole is not particularly limited as long as a through-hole of the above-described size can be formed, and can be implemented.
- it can be formed by perforation processing (drill or the like), optical fine processing (laser (eg, CO 2 laser, excimer laser, semiconductor laser, YAG laser) or the like), etching processing, embossing processing, or the like.
- the processing may be such that the shape of the through hole becomes a tapered shape. At that time, the periphery of the end is deformed, for example, as shown in FIG.
- a structure may be formed in which a portion located in the intermediate region between the opening and the adjacent opening has a different layer thickness.
- the layer having a cell adhesive surface may be a layer having a cell adhesive property immobilized on a layered substrate or a layer having a cell adhesive property.
- the thickness of the layer having a cell-adhesive surface is, for example, 1 nm or more and 4 mm or less, preferably 1 ⁇ m or more and 1 mm or less, and may be the same as the thickness of the bottom surface of the concave portion described above.
- the cell culture sheet of the present invention also includes a mode in which an adhesive layer (adhesive layer) is further provided between the above-mentioned layer having a cell-adhesive surface and the layer having a non-cell-adhesive surface.
- an adhesive layer adheresive layer
- FIG. 6 shows an example of such a case.
- An embodiment is shown in which an adhesive layer 23 is provided between a layer made of a substance 22 having cell adhesion and a portion where the substance 21 having cell non-adhesion is immobilized. .
- any one known in the art can be used.
- silicon-based resin, synthetic rubber, natural rubber and the like can be mentioned, and a low-elution adhesive layer can be preferably used.
- a commercially available double-sided tape or the like may be used.
- the thickness of the adhesive layer is not particularly limited, and can be appropriately set as long as the effects of the present invention are not impaired. For example, 0.5-100 ⁇ m is exemplified.
- the cell culture sheet of the present invention may have layers other than those described above laminated, or layers having cavities may be laminated.
- the thickness of the cell culture sheet of the present invention is not particularly limited, but is preferably from 10 to 5000 ⁇ m, more preferably from 100 to 2000 ⁇ m, from the viewpoint of handleability.
- the sheet area is not particularly limited, and is, for example, 0.01 to 10000 cm 2 , preferably 0.03 to 5000 cm 2 .
- the cell culture sheet of the present invention can be used as it is in a known cell culture device. At that time, sizing processing may be appropriately performed according to the size of the target device.
- Cells applicable to the cell culture sheet of the present invention are not limited. For example, if a cell aggregate can be formed by forming a bond with each other, by using the cell culture sheet of the present invention, cells are adhered and cultured on the cell adhesive surface on the bottom surface of the concave portion, Medium exchange and the like are easy, cell loss at the time of medium exchange can be reduced, and spheroids can be easily prepared. Regardless of the type of animal, organ, or tissue from which it is derived, any type of cell can be appropriately selected and used according to the purpose.
- any organ or tissue (brain, liver, pancreas, spleen, heart, lung, intestine, cartilage, bone, fat, etc.) of a human or non-human animal (monkey, pig, dog, rat, mouse, etc.) , Kidney, nerve, skin, bone marrow, embryo, etc.), established cell lines, or cells obtained by subjecting them to genetic manipulation or the like.
- ES cells iPS cells, neural stem cells, mesenchymal stem cells, tissue stem cells (somatic stem cells), hematopoietic stem cells, cancer stem cells, and other undifferentiated stem cells or progenitor cells
- cells derived from digestive organs such as liver cells and pancreatic cells, cells derived from circulatory organs such as kidney cells, nervous cells, and cardiomyocytes, connective tissues such as fat cells and skin dermis Differentiated cells such as fibroblasts, epithelial cells derived from epithelial tissues such as skin epidermis, bone cells, cartilage cells, cells derived from eye tissues such as retina, vascular cells, blood cells, germ cells, etc. Cells can also be used.
- cancerous cells can also be used. As such cells, one kind of cells can be used alone, or two or more kinds of cells can be used in a mixture at an arbitrary ratio.
- the cell culture sheet of the present invention has a cell non-adhesive surface having a plurality of through-holes having a diameter of 1000 ⁇ m or less from the viewpoint of production efficiency, as long as the sheet for cell culture of the present invention has the above-described configuration.
- a manufacturing method characterized by laminating a layer and a layer having a cell adhesive surface in this order is preferred.
- the section of the cell culture sheet of the present invention can be referred to.
- the lamination method may be a method of sequentially laminating each layer prepared in advance, a method of separately forming a layer on a layer prepared in advance, or a combination thereof. Specifically, for example, casting, spin coating, and roll coating a substance exhibiting cell adhesion on a release sheet whose surface has been subjected to a release treatment (for example, an organic polymer film such as a polyethylene substrate, ceramics, metal, and the like).
- a release sheet for example, an organic polymer film such as a polyethylene substrate, ceramics, metal, and the like.
- the layer having a cell-adhesive surface can be formed into a sheet by coating to an appropriate thickness and heating by such a method.
- the surface is coated with a substance having cell non-adhesive properties to prepare a layer having a cell non-adhesive surface in advance.
- a substance having cell non-adhesive properties can be. And it can manufacture by laminating
- the layers may be laminated using the above-mentioned adhesive layer (adhesive layer), or may be welded (high frequency welding, ultrasonic welding). Etc.), and may be laminated by compression bonding (such as thermocompression bonding).
- the cell culture sheet of the present invention can be used to carry out cell culture by placing a medium containing cells on one surface thereof, or by storing the sheet in various cell culture containers such as culture dishes, flasks, and culture bags. After fixing, the cell culture can be performed by adding a medium containing cells to the container. Therefore, the present invention also provides a cell culture instrument including the cell culture sheet of the present invention.
- the device for cell culture of the present invention may itself be in the form of various cell culture containers such as a culture plate such as a single or multiwell plate, a culture dish, a culture dish, a flask, and a culture bag. .
- the present invention also provides a method for culturing spheroids, which comprises culturing with the cell culture sheet or cell culture device of the present invention.
- the medium and conditions used for culturing the cells can be appropriately set according to the cells used.
- a defoaming treatment is not particularly limited, and general processes such as spraying, pipetting, shaking, temperature change such as heating and cooling, centrifugal treatment, vacuum deaeration, and ultrasonic treatment can be performed. Are spraying, pipetting, and temperature changes.
- the seeded cells are sorted by the divided shape (shape formed by a plurality of recesses), and the proper adhesion possessed by the substrate is exhibited. Therefore, the uniformity of the obtained spheroid is improved.
- spheroids can be collected simply by shaking or gently pipetting a cell culture sheet or a cell culture instrument due to excellent handling during the culture operation.
- the cell culture sheet of the present invention has a special adhesive environment due to the cell-adhesive bottom surface and the non-cell-adhesive side wall surface surrounding the cell-adhesive bottom surface in each concave portion, even though the concave portions are as small as 1000 ⁇ m or less. It is presumed that the effect of not only improving the size uniformity and circularity of the obtained spheroid, but also improving the yield, will be exhibited. However, the present invention is not restricted by these assumptions.
- the diameter of the obtained spheroid is not particularly limited, but is, for example, 10 to 1000 ⁇ m, preferably 10 to 800 ⁇ m.
- the diameter of the spheroid can be measured by a conventional method (for example, image analysis software, a particle size distribution meter), and can be displayed as, for example, a fluid diameter or a circle equivalent diameter.
- the resulting spheroid has a circularity of, for example, 0.5 to 1.0, preferably 0.7 to 1.0.
- room temperature means 20 to 30 ° C.
- Example 1 Cell culture sheet ⁇ Preparation of layer having cell adhesive surface (preparation of fluorine-containing polyimide film)>
- 2.976 g (10.2 mmol) of 1,4-bis (aminophenoxy) benzene, 4.524 g (10.2 mmol) of 4,4'-hexafluoroisopropylidene diphthalic anhydride, 42.5 N-methylpyrrolidone g was charged. After stirring at room temperature under a nitrogen atmosphere, the mixture was maintained for 5 days to obtain a fluorinated polyamic acid resin composition (solid content concentration: 15.0% by mass, 6FDA / TPEQ polyamic acid).
- the polyamic acid had a weight average molecular weight of 120,000 and a viscosity of 6 Pa ⁇ s.
- the weight average molecular weight of the polyamic acid and the weight average molecular weight of the fluorinated polyimide after firing are substantially the same.
- the fluorinated polyamic acid resin composition obtained above was applied on a glass substrate using a die coater so that the thickness of the fluorinated polyimide film after firing became 40 ⁇ m, to form a coating film.
- the coating film was baked at 360 ° C. for 1 hour under a nitrogen atmosphere. Thereafter, the fired product was peeled from the glass substrate to obtain a fluorine-containing polyimide film.
- the static water contact angle of this fluorinated polyimide film was 83.0 ° and the falling angle was 24.0 °.
- the method for measuring the physical properties in the above is as follows.
- Equipment HCL-8220GPC manufactured by Tosoh Corporation
- Column TSKgel Super AWM-H Eluent (LiBr ⁇ H2O, NMP containing phosphoric acid): 0.01 mol / L
- Measurement method A 0.5% by weight solution is prepared with an eluent, and the molecular weight is calculated based on a calibration curve prepared with polystyrene.
- Apparatus Viscometer VISCOMETER TV-22 made by AS ONE Setting: VI RANGE: H ROTOR No.
- Apparatus Automatic contact angle meter (DM-500, manufactured by Kyowa Interface Science) Measuring method: After dropping 25 ⁇ L of water on the film, the base material is continuously inclined, and the angle at the time of falling is defined as the falling angle (measuring temperature: 25 ° C.).
- ⁇ Preparation of layer having cell non-adhesive surface> After peeling the single-sided release tape of a double-sided tape (25 ⁇ m) and bonding it to a transparent PET film (250 ⁇ m), use a CO 2 laser to create a staggered through hole with a diameter of 300 ⁇ m and a pitch of 500 ⁇ m using a CO2 laser. Formed (formed through holes: 400 / cm 2 , 24000 / sheet, laser incident side hole diameter 500 ⁇ m, laser emission side hole diameter 300 ⁇ m).
- the surface of the PET film was coated with an MPC polymer solution (0.5% ethanol solution, hydrophobic MPC polymer) using a spin coater (Mikasa: MS-A150) so that the thickness became 0.05 ⁇ m (spin conditions: 1000 rpm, 10 seconds) and drying treatment in a dryer at 50 ° C. for 2 hours to obtain a layer having a cell non-adhesive surface [static water contact angle 107.degree. On the PET film coating layer (MPC polymer coating layer) side. 5 °].
- MPC polymer solution 0.5% ethanol solution, hydrophobic MPC polymer
- ⁇ Preparation of cell culture sheet and culture container> the layer having the cell-adhesive surface prepared above was attached to the surface of the double-sided tape of the layer having the cell-non-adhesive surface from which the other release tape had been removed, to prepare a cell culture sheet. (Sheet thickness: 315 ⁇ m). The obtained cell culture sheet was placed in a culture plate to complete a container used for cell culture.
- Test example 1 The cells used were human adipose derived stem cells (AdSC).
- AdSC purchased and used a manufacturer product (Lonza, PT-5006).
- Example 1 ⁇ Defoaming treatment> Separately, the culture vessel of Example 1 was defoamed. Specifically, about 25 mL of PBS was added to the container, and pipetting was repeated twice to remove bubbles. Next, 12 mL of KBM ADSC-2 medium containing 1% antibiotics was added, and the mixture was allowed to stand in a 5% (v / v) CO 2 incubator at 37 ° C. overnight.
- ⁇ Culture of spheroids> After removing the medium from the culture flask and adding 5 mL of a cell detachment solution accutase (promocell), the cells were detached by keeping the mixture in a 5% (v / v) CO 2 incubator at 37 ° C. for about 5 minutes. Next, the stripping solution was recovered and transferred to a tube using PBS so that the total amount became 25 mL. After centrifugation at 500 ⁇ g for 5 minutes, the cells were suspended in 10 mL of KBM ADSC-2 medium containing 1% antibiotics, and the number of cells was counted. Thereafter, it was adjusted to a concentration of 1.0 ⁇ 10 6 cells / mL.
- the medium in the culture vessel subjected to the defoaming treatment by leaving still in a 5% (v / v) CO 2 incubator at 37 ° C. overnight is removed, and the cells are cultured at 500 cells / well or 200 cells / well. Seeded. After standing in a safety cabinet for 15 minutes, it was placed in a 5% (v / v) CO 2 incubator at 37 ° C. for 4 hours. Next, KBM ADSC-2 medium containing an additional 1% antibiotic was added, and the cells were cultured again in a 5% (v / v) CO 2 incubator at 37 ° C. (day 0 of culture). The culture was performed until the 14th day.
- the obtained spheroids had high uniformity in size (500 cells / well: equivalent circle diameter 151-179 ⁇ m, SD 14-16 ⁇ m, 200 cells / well: equivalent circle diameter 116-130 ⁇ m, SD 14-15 ⁇ m)
- the circularity was high (500 cells / well: circularity ⁇ ⁇ 0.841-0.873, SD 0.067-0.083, 200 cells / well: circularity 0.849-0.882, SD 0.080-0.086). It was also found that spheroids having different sizes can be obtained by changing the number of seeded cells. Therefore, a uniform and large amount of spheroids could be stably and easily obtained by using the cell culture sheet of the present invention.
- Test example 2 Using a cell culture sheet prepared and defoamed in the same manner as in Example 1, a human bone marrow-derived mesenchymal stem cell line (UE7T-13 cell; JCRB1154) was cultured. The medium used was DMEM + 10% FBS.
- the cell culture sheet was divided into nine sections from point A to point I (FIG. 11), spheroids were photographed for each, and the circle-equivalent diameter of the spheroids was analyzed using image analysis software WinROOF (manufactured by Mitani Corporation) (FIG. 12). Indicates the analysis results on the third day of culture).
- the obtained spheroids were highly uniform in size (3rd day of culture: equivalent circle diameter 96 ⁇ m, SD 8 ⁇ m, 4th day of culture: equivalent circle diameter 97 ⁇ m, SD 9 ⁇ m). I knew it wasn't.
- Test example 3 The cells were cultured in the same manner as in Test Example 2 except that the number of seeded cells was 1.2 ⁇ 10 7 cells (500 cells per well) in the cell culture sheet, and the equivalent circle diameter of spheroids was evaluated on the first day of culture. (FIG. 13).
- the obtained spheroids had high uniformity in size (the first day of culture: equivalent circle diameter 151 ⁇ m, SD 11 ⁇ m), and did not vary depending on the category.
- Examples 2 to 5 A cell culture container was prepared in the same manner as in Example 1 except that the preparation of a layer having a cell adhesive surface (preparation of a fluorine-containing polyimide film) was performed as follows.
- the weight average molecular weight of the polyamic acid in each of the examples is substantially the same as the weight average molecular weight of the fluorinated polyimide after firing.
- Example 2 6FDA / TFMB
- 21.792 g (0.049 mol) of 4,4′-hexafluoroisopropylidene diphthalic anhydride and 148.75 g of N-methylpyrrolidone were charged and dissolved.
- a fluorinated polyamic acid resin composition (solid content concentration: 15% by mass, 6FDA / TFMB polyamic acid) was obtained.
- the polyamic acid had a weight average molecular weight of 189,000 and a viscosity of 9.1 Pa ⁇ s.
- a fluorinated polyimide film was obtained in the same manner as in Example 1.
- the static water contact angle of this fluorinated polyimide film was 82.1 °, and the falling angle was 19.9 °.
- Example 3 6FDA / ODA
- 26.89 g (0.058 mol) of 4,4'-hexafluoroisopropylidene diphthalic anhydride and 154.7 g of N-methylpyrrolidone were charged and dissolved.
- a solution prepared by dissolving 12.11 g (0.058 mol) of 4,4′-diaminodiphenyl ether and 66.3 g of N-methylpyrrolidone was added dropwise thereto, followed by stirring at room temperature under a nitrogen atmosphere and holding for 5 days.
- a fluorinated polyamic acid resin composition solid content: 15% by mass, 6FDA / ODA polyamic acid
- the polyamic acid had a weight average molecular weight of 150,000 and a viscosity of 7.7 Pa ⁇ s.
- a fluorinated polyimide film was obtained in the same manner as in Example 1.
- the static water contact angle of this fluorinated polyimide film was 79.5 °, and the falling angle was 31.0 °.
- Example 4 6FDA / BAPP
- 19.49 g (0.044 mol) of 4,4'-hexafluoroisopropylidene diphthalic anhydride and 148.75 g of N-methylpyrrolidone were charged and dissolved.
- a fluorinated polyamic acid resin composition (solid content: 15% by mass, 6FDA / BAPP polyamic acid) was obtained.
- the polyamic acid had a weight average molecular weight of 185,000 and a viscosity of 7.1 Pa ⁇ s.
- a fluorinated polyimide film was obtained in the same manner as in Example 1.
- the static water contact angle of this fluorinated polyimide film was 82.5 ° and the falling angle was 32.2 °.
- Example 5 6FDA / BAPB
- 20.50 g (0.046 mol) of 4,4′-hexafluoroisopropylidene diphthalic anhydride and 148.75 g of N-methylpyrrolidone were charged and dissolved.
- a fluorinated polyamic acid resin composition (solid content concentration: 15% by mass, 6FDA / BAPB polyamic acid) was obtained.
- the polyamic acid had a weight average molecular weight of 112,000 and a viscosity of 8.1 Pa ⁇ s.
- a fluorinated polyimide film was obtained in the same manner as in Example 1.
- the static water contact angle of this fluorinated polyimide film was 79.0 °, and the falling angle was 32.2 °.
- Test example 4 The same cells as those used in Test Example 1 were used.
- ⁇ Defoaming of container> The culture containers of Examples 2 to 5 were subjected to defoaming treatment. Specifically, about 2 ML of PBS was added to the container, and pipetting was repeated twice to remove bubbles. Next, 0.2 mL of KBM ADSC-2 medium containing 1% antibiotics was added, and the mixture was allowed to stand in a 5% (v / v) CO 2 incubator at 37 ° C. overnight.
- ⁇ Culture of spheroids> After removing the culture medium from the culture flask and adding 5 mL of a cell detachment solution accutase (promocell), the cells were detached by keeping them in a 5% (v / v) CO 2 incubator at 37 ° C. for about 5 minutes. Next, the stripping solution was collected and transferred to a tube using PBS so that the total amount became 15 mL. The cells were centrifuged at 210 ⁇ g for 5 minutes, suspended in 2 mL of KBM ADSC-2 medium containing 1% antibiotics, and the number of cells was counted. Thereafter, it was adjusted to a concentration of 1.0 ⁇ 10 6 cells / mL.
- the culture medium in the culture vessel which was allowed to stand overnight in a 5% (v / v) CO 2 incubator at 37 ° C., was removed, and cells were seeded at 500 cells / well. Thereafter, the culture was started in the same manner as in Test Example 1, and the culture was performed until the third day. The morphology of the obtained spheroid was photographed in the same manner as in Test Example 1.
- FIG. 14 shows the results.
- the cell culture sheet of the present invention can be easily prepared, the cell culture operation is easy, and the uniformity of the obtained cell tissue can be improved.
- the cell culture sheet of the present invention can be easily prepared and the cell culture operation itself can be performed efficiently, it is preferably used in the field of cell preparations such as spheroid-containing preparations. be able to.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Sustainable Development (AREA)
- Clinical Laboratory Science (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
〔1〕 開口部の孔径が直径1000μm以下の凹部を複数有し、該凹部の内側面が細胞非接着性表面を有し、かつ、該凹部の底面が細胞接着性表面を有する、細胞培養用シート。
〔2〕 貫通孔を有する細胞非接着性表面を有する層と、細胞接着性表面を有する層との積層物である、前記〔1〕記載の細胞培養用シート。
〔3〕 細胞非接着性表面を有する層と細胞接着性表面を有する層との間に、さらに接着層を含む、前記〔2〕記載の細胞培養用シート。
〔4〕 細胞接着性表面が合成樹脂で構成される、前記〔1〕~〔3〕のいずれかに記載の細胞培養用シート。
〔5〕 細胞接着性表面がポリイミドを含む樹脂組成物で構成される、前記〔1〕~〔4〕のいずれかに記載の細胞培養用シート。
〔6〕 凹部が底面側に向かってテーパー状に形成されている、前記〔1〕~〔5〕のいずれかに記載の細胞培養用シート。
〔7〕 凹部が単位面積(cm2)あたり10~1000個の個数で形成されている、前記〔1〕~〔6〕のいずれかに記載の細胞培養用シート。
〔8〕 直径1000μm以下の貫通孔を複数有する細胞非接着性表面を有する層及び細胞接着性表面を有する層を積層する、細胞培養用シートの製造方法。
〔9〕 前記〔1〕~〔7〕のいずれかに記載の細胞培養用シートを含む、細胞培養用器具。
〔10〕 前記〔1〕~〔7〕、〔9〕のいずれかに記載の細胞培養用シート又は細胞培養用器具で培養する、スフェロイドの培養方法。
このような物質の一例を示すと、ポリエチレングリコール及びその誘導体、MPC(2-メタクリロイルオキシエチルホスホリルコリン)、poly-HEMA(ポリヒドロキシエチルメタクリレート)、SPC(セグメント化ポリウレタン)等の化合物や、生体から取得されたタンパク質(アルブミン等)を、細胞の種類に応じて適宜選択して用いることができる。なかでも、基材に用いる合成樹脂との接着性の観点から、または、細胞培養用シートの製造工程を簡素化できる観点から、または得られる細胞組織体の均一性が向上する観点等から、MPC(2-メタクリロイルオキシエチルホスホリルコリン)が好ましい。
なお、物質は、取扱性、所望の疎水性(例えば、超疎水性)・親水性(例えば、超親水性)の程度等に応じて、適宜、変性したものを使用してもよい。例えば、親水性の物質を架橋処理等することで、親水性と水に対する低溶解性を両立させてもよい。また、原料となる物質(例えば、疎水性又は親水性)を、適宜、疎水化処理ないし親水化処理(例えば、疎水性基ないし親水性基の導入等)し、所望の疎水性ないし親水性の材質を得てもよい。
一方、親水性表面である場合、静的水接触角は好ましくは65°以下、より好ましくは55°以下、更に好ましくは50°以下となる。また、0°以上となってもよく、好ましくは5°以上、より好ましくは10°以上である。
一例を挙げると、疎水性が高いMPC(又は当該MPCで形成された表面)では、静的水接触角が、例えば、90°以上、100°以上のような静的水接触角を実現しうる。
なお、このような静的水接触角は、細胞非接着性表面における値であってもよく、細胞非接着性を示す物質(又は細胞非接着性表面を構成する物質)における値であってもよい。
また、静的水接触角は、例えば、後述の方法等により測定してもよい。
Yは2価の有機基を示し;
Z1、Z2、Z3、Z4、Z5、及びZ6は互いに独立して水素原子、フッ素原子、塩素原子、臭素原子またはヨウ素原子のいずれかを示し、
pは0または1である。
なお、ポリイミド樹脂において、式(I)で示される化学構造は、樹脂の構成単位ごとに異なってもよく、同一であってもよい。X0、Y、Z1、Z2、Z3、Z4、Z5、及びZ6の少なくとも1つはフッ素原子を1個以上含むことが好ましい。
装置:東ソー株式会社製HCL-8220GPC
カラム:TSKgel Super AWM-H
溶離液(LiBr・H2O、リン酸入りNMP):0.01mol/L
測定方法:0.5重量%の溶液を溶離液で作製し、ポリスチレンで作製した検量線をもとに分子量を算出する。
細胞接着性物質又は細胞接着性表面がこのような条件を満たすことにより、スフェロイド形成がより一層促進される。
スフェロイドの接着性およびスフェロイド形成性の観点から、静的水接触角は、より好ましくは75°以上(例えば、75°超)であり、さらに好ましくは77°以上、さらに好ましくは79°以上、よりさらに好ましくは80°以上(例えば、80°超)であり、静的水接触角の上限は、例えば150°未満であり、好ましくは120°以下(例えば、120°未満)であり、より好ましくは110°以下であり、さらに好ましくは100℃以下(例えば、99℃未満、98℃以下、97℃以下、95℃以下等)である。
一方、細胞接着性物質又は細胞接着性表面[親水性(特に、超親水性でない親水性)の細胞接着性物質又は細胞接着性表面]は、静的水接触角65°以下、より好ましくは55°以下、更に好ましくは50°以下を有していてもよい。なお、下限値は、0°以上となってもよく、好ましくは5°以上、より好ましくは10°以上であってもよい。
スフェロイド形成性の観点から、転落角は、18°以上、19°以上、20°以上、22°以上、24°以上、26°以上、28°以上、30°以上の順で高いほど好ましい。転落角の上限値は、例えば80°未満であり、好ましくは70°以下(例えば、70°未満)であり、より好ましくは60°以下(例えば、60°未満)であり、さらに好ましくは50°以下(例えば、50°未満)である。なお、上記の静的水接触角や転落角は、以下の方法により測定される値であってもよい。
装置:自動接触角計(協和界面科学製:DM-500)
測定方法:表面(細胞非接着性表面又は細胞接着性表面)又はフィルム(細胞非接着性又は細胞接着性の物質で形成したフィルム)上に水2μLを滴下した直後の液滴の付着角度を測定する(測定温度:25℃)。
装置:自動接触角計(協和界面科学製:DM-500)
測定方法:表面(細胞非接着性表面又は細胞接着性表面)又はフィルム(細胞非接着性又は細胞接着性の物質で形成したフィルム)上に水25μLを滴下した後、基材を連続的に傾けていき、流れ落ちた際の角度を転落角とする(測定温度:25℃)。
<細胞接着性表面を有する層の調製(含フッ素ポリイミドフィルムの調製)>
100mL容量の三口フラスコに、1,4-ビス(アミノフェノキシ)ベンゼン2.976g(10.2ミリモル)、4,4’-ヘキサフルオロイソプロピリデンジフタル酸無水物4.524g(10.2ミリモル)、N-メチルピロリドン42.5gを仕込んだ。窒素雰囲気下室温で撹拌後、5日間保持することで、含フッ素ポリアミド酸樹脂組成物(固形分濃度15.0質量%、6FDA/TPEQポリアミド酸)を得た。該ポリアミド酸の重量平均分子量は12万で、粘度は6Pa・sであった。なお、ポリアミド酸の重量平均分子量と、焼成後の含フッ素ポリイミドの重量平均分子量とは実質的に同一である。
(重量平均分子量の測定)
装置:東ソー株式会社製HCL-8220GPC
カラム:TSKgel Super AWM-H
溶離液(LiBr・H2O、リン酸入りNMP):0.01mol/L
測定方法:0.5重量%の溶液を溶離液で作製し、ポリスチレンで作製した検量線をもとに分子量を算出する。
(粘度の測定)
装置:アズワン製 粘度計 VISCOMETER TV-22
設定:VI RANGE:H ROTOR No.6 SPEED:10rpm
粘度計校正用標準液:日本グリース(株) JS 14000
測定方法:粘度計校正用標準液で校正後、ワニス0.3gを用いて測定する。(測定温度:23℃)
(静的水接触角の測定)
装置:自動接触角計(協和界面科学製:DM-500)
測定方法:フィルム上に水2μLを滴下した直後の液滴の付着角度を測定する(測定温度:25℃)。
(転落角の測定)
装置:自動接触角計(協和界面科学製:DM-500)
測定方法:フィルム上に水25μLを滴下した後、基材を連続的に傾けていき、流れ落ちた際の角度を転落角とする(測定温度:25℃)。
両面テープ(厚み25μm)の片面の剥離テープを剥離後透明なPETフィルム(厚み250μm)に貼り合わせたものに対して、CO2レーザーを用いて、直径300μm、ピッチ500μmで千鳥配置の貫通孔を形成した(形成された貫通孔:400個/cm2、24000個/シート、レーザー入射側孔径500μm、レーザー放出側孔径300μm)。その後、PETフィルム側の表面にスピンコーター(ミカサ製:MS-A150)を用いて、MPCポリマー溶液(0.5%エタノール溶液、疎水性MPCポリマー)を厚みが0.05μmとなるようにコーティング(スピン条件:1000rpm、10秒間)し、50℃の乾燥機内で2時間乾燥処理して、細胞非接着性表面を有する層[PETフィルムのコーティング層(MPCポリマーのコーティング層)側の静的水接触角107.5°]を得た。
次いで、細胞非接着性表面を有する層の両面テープのもう一方の剥離テープを除去した側の面に、上記で作製した細胞接着性表面を有する層を貼りあわせて、細胞培養用シートを調製した(シート厚み:315μm)。得られた細胞培養シートを培養プレート内へ設置し、細胞培養に用いる容器を完成した。
細胞は、ヒト脂肪由来幹細胞(Human adipose derived stem cell:AdSC)を用いた。AdSCはメーカー品(ロンザ社、PT-5006)を購入して使用した。
凍結細胞を37℃の恒温水槽で溶解させ、5%FBS、1%抗生物質を含んだKBM ADSC-2培地(基礎培地、コージンバイオ製)9mLに加えた。次いで、500×gで5分間の遠心処理を施した後、上清を除去して10mLの基礎培地に分散させた。800mL容細胞培養用フラスコ(住友ベークライト製)に細胞懸濁液を加えた後の全量が30mLとなるように基礎培地を予め加えておき、そこに細胞懸濁液を1.0×106細胞/フラスコとなるように加え、37℃の5%(v/v)CO2インキュベーター内で培養(拡大培養)を行った。
別途、実施例1の培養容器の脱泡処理を行った。具体的には、容器に25mL程度のPBSを加えてピペッティングの作業を2度繰り返し、脱泡を行った。次いで、1%抗生物質を含んだKBM ADSC-2培地を12mL加えて、37℃の5%(v/v)CO2インキュベーター内で1晩静置した。
培養用フラスコから培地を除去し、細胞剥離液accutase(プロモセル製)を5mL添加した後、37℃の5%(v/v)CO2インキュベーター内で5分程度保持して細胞を剥離した。次いで、剥離液を回収し、PBSを用いて総量が25mLとなるようにしてチューブへ移した。500×gで5分間遠心処理を施し、10mLの1%抗生物質を含んだKBM ADSC-2培地で懸濁させて、細胞数のカウントを行った。その後、1.0×106細胞/mLの濃度となるように調製した。
培養3日目、6日目、14日目にスフェロイドを撮影し(図7)、画像解析ソフトであるWinROOF(三谷商事製)でスフェロイドの円相当径、流体直径、円形度を解析した(図8~10)。
実施例1と同様にして調製して脱泡処理した細胞培養シートを用いて、ヒト骨髄由来間葉系幹細胞株(UE7T-13細胞;JCRB1154)の培養を行った。培地はDMEM+10%FBSを使用した。
播種細胞数が、細胞培養シートに1.2×107細胞(1ウェルあたり500細胞)となる以外は、試験例2と同様に細胞を培養して、培養1日目にスフェロイドの円相当径を評価した(図13)。
細胞接着性表面を有する層の調製(含フッ素ポリイミドフィルムの調製)を下記の通りに行なう以外は、実施例1と同様にして、細胞培養用容器を調製した。なお、各実施例におけるポリアミド酸の重量平均分子量と、焼成後の含フッ素ポリイミドの重量平均分子量とは実質的に同一である。
500mL容量の三口フラスコに、4,4’-ヘキサフルオロイソプロピリデンジフタル酸無水物21.792g(0.049モル)、N-メチルピロリドン148.75gを仕込み溶解した。そこへ2,2’-ビス(トリフルオロメチル)ベンジジン15.708g(0.049モル)、N-メチルピロリドン63.75gを仕込み溶解したものを滴下投入し、窒素雰囲気下室温で撹拌後、5日間保持することで、含フッ素ポリアミド酸樹脂組成物(固形分濃度15質量%、6FDA/TFMBポリアミド酸)を得た。該ポリアミド酸の重量平均分子量は18.9万で、粘度は9.1Pa・sであった。得られた含フッ素ポリアミド酸樹脂組成物を用いて、実施例1と同様にして含フッ素ポリイミドフィルムを得た。この含フッ素ポリイミドフィルムの静的水接触角は82.1°、転落角は19.9°であった。
500mL容量の三口フラスコに、4,4’-ヘキサフルオロイソプロピリデンジフタル酸無水物26.89g(0.058モル)、N-メチルピロリドン154.7gを仕込み溶解した。そこへ4,4’-ジアミノジフェニルエーテル12.11g(0.058モル)、N-メチルピロリドン66.3gを仕込み溶解したものを滴下投入し、窒素雰囲気下室温で撹拌後、5日間保持することで、含フッ素ポリアミド酸樹脂組成物(固形分濃度15質量%、6FDA/ODAポリアミド酸)を得た。該ポリアミド酸の重量平均分子量は15.3万で、粘度は7.7Pa・sであった。得られた含フッ素ポリアミド酸樹脂組成物を用いて、実施例1と同様にして含フッ素ポリイミドフィルムを得た。この含フッ素ポリイミドフィルムの静的水接触角は79.5°、転落角は31.0°であった。
500mL容量の三口フラスコに、4,4’-ヘキサフルオロイソプロピリデンジフタル酸無水物19.49g(0.044モル)、N-メチルピロリドン148.75gを仕込み溶解した。そこへ2,2-ビス(4-(4-アミノフェノキシ)フェニル)プロパン18.01g(0.044モル)、N-メチルピロリドン63.75gを仕込み溶解したものを滴下投入し、窒素雰囲気下室温で撹拌後、5日間保持することで、含フッ素ポリアミド酸樹脂組成物(固形分濃度15質量%、6FDA/BAPPポリアミド酸)を得た。該ポリアミド酸の重量平均分子量は18.5万で、粘度は7.1Pa・sであった。得られた含フッ素ポリアミド酸樹脂組成物を用いて、実施例1と同様にして含フッ素ポリイミドフィルムを得た。この含フッ素ポリイミドフィルムの静的水接触角は82.5°、転落角は32.2°であった。
500mL容量の三口フラスコに、4,4’-ヘキサフルオロイソプロピリデンジフタル酸無水物20.50g(0.046モル)、N-メチルピロリドン148.75gを仕込み溶解した。そこへ4,4’-ビス(4-アミノフェノキシ)ビフェニル17.00g(0.046モル)、N-メチルピロリドン63.75gを仕込み溶解したものを滴下投入し、窒素雰囲気下室温で撹拌後、5日間保持することで、含フッ素ポリアミド酸樹脂組成物(固形分濃度15質量%、6FDA/BAPBポリアミド酸)を得た。該ポリアミド酸の重量平均分子量は11.2万で、粘度は8.1Pa・sであった。得られた含フッ素ポリアミド酸樹脂組成物を用いて、実施例1と同様にして含フッ素ポリイミドフィルムを得た。この含フッ素ポリイミドフィルムの静的水接触角は79.0°、転落角は32.2°であった。
使用する細胞は、試験例1と同じものを用いた。
凍結細胞を37℃の恒温水槽で溶解させ、5%FBS、1%抗生物質を含んだKBM ADSC-2培地(基礎培地、コージンバイオ製)9mLに加えた。次いで、210×gで5分間の遠心処理を施した後、上清を除去して1mLの基礎培地に分散させた。800mL細胞培養用フラスコ(住友ベークライト製)に細胞懸濁液を加えた後の全量が30mLとなるように基礎培地を予め加えておき、そこに細胞懸濁液を1.0×106細胞/フラスコとなるように加え、37℃の5%(v/v)CO2インキュベーター内で培養を行った。
実施例2~5の培養容器の脱泡処理を行った。具体的には、容器に2ML程度のPBSを加えてピペッティングの作業を2度繰り返し、脱泡を行った。次いで、1%抗生物質を含んだKBM ADSC-2培地を0.2mL加えて、37℃の5%(v/v)CO2インキュベーター内で1晩静置した。
培養用フラスコから培地を除去し、細胞剥離液accutase(プロモセル製)を5mL添加した後、37℃の5%(v/v)CO2インキュベーター内で5分程度保持して細胞を剥離した。次いで、剥離液を回収し、PBSを用いて総量が15mLとなるようにしてチューブへ移した。210×gで5分間遠心処理を施し、2mLの1%抗生物質を含んだKBM ADSC-2培地で懸濁させて、細胞数のカウントを行った。その後、1.0×106細胞/mLの濃度となるように調製した。
11 凹部
11a 凹部の内側面
11b 凹部の底面
12 シート表面
21 細胞非接着性を示す物質
22 細胞接着性を示す物質
23 接着層
Claims (10)
- 開口部の孔径が直径1000μm以下の凹部を複数有し、該凹部の内側面が細胞非接着性表面を有し、かつ、該凹部の底面が細胞接着性表面を有する、細胞培養用シート。
- 貫通孔を有する細胞非接着性表面を有する層と、細胞接着性表面を有する層との積層物である、請求項1記載の細胞培養用シート。
- 細胞非接着性表面を有する層と細胞接着性表面を有する層との間に、さらに接着層を含む、請求項2記載の細胞培養用シート。
- 細胞接着性表面が合成樹脂で構成される、請求項1~3のいずれかに記載の細胞培養用シート。
- 細胞接着性表面がポリイミドを含む樹脂組成物で構成される、請求項1~4のいずれかに記載の細胞培養用シート。
- 凹部が底面側に向かってテーパー状に形成されている、請求項1~5のいずれかに記載の細胞培養用シート。
- 凹部が単位面積(cm2)あたり10~1000個の個数で形成されている、請求項1~6のいずれかに記載の細胞培養用シート。
- 直径1000μm以下の貫通孔を複数有する細胞非接着性表面を有する層及び細胞接着性表面を有する層を積層する、細胞培養用シートの製造方法。
- 請求項1~7のいずれかに記載の細胞培養用シートを含む、細胞培養用器具。
- 請求項1~7、9のいずれかに記載の細胞培養用シート又は細胞培養用器具で培養する、スフェロイドの培養方法。
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/258,940 US20210123012A1 (en) | 2018-07-10 | 2019-07-09 | Cell culture sheet |
EP19834416.0A EP3822336A4 (en) | 2018-07-10 | 2019-07-09 | CELL CULTURE FILM |
KR1020207037805A KR102660682B1 (ko) | 2018-07-10 | 2019-07-09 | 세포 배양용 시트 |
JP2020530212A JP7105887B2 (ja) | 2018-07-10 | 2019-07-09 | 細胞培養用シート |
CN201980046075.4A CN112384604A (zh) | 2018-07-10 | 2019-07-09 | 细胞培养用片 |
SG11202100146XA SG11202100146XA (en) | 2018-07-10 | 2019-07-09 | Cell culture sheet |
AU2019302182A AU2019302182A1 (en) | 2018-07-10 | 2019-07-09 | Cell culture sheet |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018131132 | 2018-07-10 | ||
JP2018-131132 | 2018-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020013207A1 true WO2020013207A1 (ja) | 2020-01-16 |
Family
ID=69142009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2019/027228 WO2020013207A1 (ja) | 2018-07-10 | 2019-07-09 | 細胞培養用シート |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210123012A1 (ja) |
EP (1) | EP3822336A4 (ja) |
JP (1) | JP7105887B2 (ja) |
KR (1) | KR102660682B1 (ja) |
CN (1) | CN112384604A (ja) |
AU (1) | AU2019302182A1 (ja) |
SG (1) | SG11202100146XA (ja) |
WO (1) | WO2020013207A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020175410A1 (ja) * | 2019-02-25 | 2020-09-03 | 株式会社日本触媒 | 細胞スフェロイドの製造方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115895884A (zh) * | 2022-11-30 | 2023-04-04 | 苏州大学 | 一种用于细胞三维培养的超疏水孔板,多器官微流控芯片及其应用 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006121991A (ja) | 2004-10-29 | 2006-05-18 | Kitakyushu Foundation For The Advancement Of Industry Science & Technology | 細胞組織体マイクロチップ |
JP2008199962A (ja) | 2007-02-20 | 2008-09-04 | Fujifilm Corp | 組織体形成用基材、組織体形成キット、それを用いた組織体形成法、及び該組織体形成法により形成された三次元組織体 |
WO2009034927A1 (ja) * | 2007-09-12 | 2009-03-19 | Kitakyushu Foundation For The Advancement Of Industry, Science And Technology | 細胞培養器具及びこれを用いた細胞培養方法 |
JP2010233456A (ja) * | 2009-03-30 | 2010-10-21 | Kitakyushu Foundation For The Advancement Of Industry Science & Technology | 細胞集合体形成器具、細胞集合体培養器具、細胞集合体転写キット及び細胞集合体の培養方法 |
WO2011083768A1 (ja) * | 2010-01-08 | 2011-07-14 | 住友ベークライト株式会社 | 細胞凝集塊形成用培養容器 |
WO2015163043A1 (ja) * | 2014-04-22 | 2015-10-29 | 株式会社日本触媒 | フッ素含有ポリマーを表面に含む細胞培養用基材 |
JP2016103982A (ja) * | 2013-03-12 | 2016-06-09 | 東京エレクトロン株式会社 | 細胞培養容器、細胞培養装置、及び細胞培養方法 |
JP2016520307A (ja) * | 2013-04-30 | 2016-07-14 | コーニング インコーポレイテッド | スフェロイド細胞培養ウェル製品およびその方法 |
JP2017209081A (ja) * | 2016-05-27 | 2017-11-30 | クアーズテック株式会社 | 細胞培養担体および細胞培養モジュール |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5088995A (en) * | 1990-06-22 | 1992-02-18 | Baxter International Inc. | Port and closure assembly including a resealing injection site for a container |
JP2004254622A (ja) * | 2003-02-26 | 2004-09-16 | Yamanashi Tlo:Kk | 胚性幹細胞(es細胞)の胚様体(eb)形成のための培養容器及び培養方法 |
JP4033265B2 (ja) * | 2004-10-29 | 2008-01-16 | 財団法人北九州産業学術推進機構 | 細胞組織体マイクロデバイス |
JP5616729B2 (ja) * | 2009-09-18 | 2014-10-29 | 日本化学工業株式会社 | 連続晶析装置 |
JP5753148B2 (ja) | 2012-11-06 | 2015-07-22 | 日本写真印刷株式会社 | 細胞培養担体を用いて行うスフェロイドの培養方法と細胞培養担体 |
WO2014156455A1 (ja) * | 2013-03-28 | 2014-10-02 | 富士フイルム株式会社 | 細胞培養用具 |
JP3215918U (ja) | 2017-11-30 | 2018-04-26 | Agcテクノグラス株式会社 | 培養基材 |
-
2019
- 2019-07-09 KR KR1020207037805A patent/KR102660682B1/ko active IP Right Grant
- 2019-07-09 SG SG11202100146XA patent/SG11202100146XA/en unknown
- 2019-07-09 EP EP19834416.0A patent/EP3822336A4/en active Pending
- 2019-07-09 CN CN201980046075.4A patent/CN112384604A/zh active Pending
- 2019-07-09 WO PCT/JP2019/027228 patent/WO2020013207A1/ja unknown
- 2019-07-09 JP JP2020530212A patent/JP7105887B2/ja active Active
- 2019-07-09 US US17/258,940 patent/US20210123012A1/en active Pending
- 2019-07-09 AU AU2019302182A patent/AU2019302182A1/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006121991A (ja) | 2004-10-29 | 2006-05-18 | Kitakyushu Foundation For The Advancement Of Industry Science & Technology | 細胞組織体マイクロチップ |
JP2008199962A (ja) | 2007-02-20 | 2008-09-04 | Fujifilm Corp | 組織体形成用基材、組織体形成キット、それを用いた組織体形成法、及び該組織体形成法により形成された三次元組織体 |
WO2009034927A1 (ja) * | 2007-09-12 | 2009-03-19 | Kitakyushu Foundation For The Advancement Of Industry, Science And Technology | 細胞培養器具及びこれを用いた細胞培養方法 |
JP2010233456A (ja) * | 2009-03-30 | 2010-10-21 | Kitakyushu Foundation For The Advancement Of Industry Science & Technology | 細胞集合体形成器具、細胞集合体培養器具、細胞集合体転写キット及び細胞集合体の培養方法 |
WO2011083768A1 (ja) * | 2010-01-08 | 2011-07-14 | 住友ベークライト株式会社 | 細胞凝集塊形成用培養容器 |
JP2016103982A (ja) * | 2013-03-12 | 2016-06-09 | 東京エレクトロン株式会社 | 細胞培養容器、細胞培養装置、及び細胞培養方法 |
JP2016520307A (ja) * | 2013-04-30 | 2016-07-14 | コーニング インコーポレイテッド | スフェロイド細胞培養ウェル製品およびその方法 |
WO2015163043A1 (ja) * | 2014-04-22 | 2015-10-29 | 株式会社日本触媒 | フッ素含有ポリマーを表面に含む細胞培養用基材 |
JP2017209081A (ja) * | 2016-05-27 | 2017-11-30 | クアーズテック株式会社 | 細胞培養担体および細胞培養モジュール |
Non-Patent Citations (1)
Title |
---|
See also references of EP3822336A4 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020175410A1 (ja) * | 2019-02-25 | 2020-09-03 | 株式会社日本触媒 | 細胞スフェロイドの製造方法 |
JPWO2020175410A1 (ja) * | 2019-02-25 | 2021-11-18 | 株式会社日本触媒 | 細胞スフェロイドの製造方法 |
EP3933034A4 (en) * | 2019-02-25 | 2022-12-07 | Nippon Shokubai Co., Ltd. | PROCESS FOR THE PRODUCTION OF A CELLULAR SPHEROID |
Also Published As
Publication number | Publication date |
---|---|
EP3822336A4 (en) | 2022-05-11 |
EP3822336A1 (en) | 2021-05-19 |
KR20210018334A (ko) | 2021-02-17 |
US20210123012A1 (en) | 2021-04-29 |
KR102660682B1 (ko) | 2024-04-26 |
JP7105887B2 (ja) | 2022-07-25 |
JPWO2020013207A1 (ja) | 2021-06-24 |
SG11202100146XA (en) | 2021-02-25 |
AU2019302182A1 (en) | 2021-03-04 |
CN112384604A (zh) | 2021-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015163043A1 (ja) | フッ素含有ポリマーを表面に含む細胞培養用基材 | |
JP7105887B2 (ja) | 細胞培養用シート | |
JP2021169523A (ja) | 細胞製剤 | |
JP6228399B2 (ja) | コーティング用含フッ素ポリイミド樹脂組成物、それから得られるフィルム及びコーティング膜 | |
JP7421909B2 (ja) | 細胞の輸送方法 | |
JP6681664B2 (ja) | 含フッ素ポリイミドを含む酸素ガス透過性の細胞培養用基材、該基材を備えた細胞培養用容器、及び、該基材を用いた細胞培養方法 | |
WO2021029241A1 (ja) | 細胞培養用基材 | |
JP6488163B2 (ja) | 細胞培養用基材 | |
US20200129377A1 (en) | Medical film and method for producing same, medical coating composition, medical device and method for producing same | |
JP7263512B2 (ja) | 細胞及び/又はその集合体の回収方法 | |
JP2017077241A (ja) | 接着性細胞培養用基材、ならびにこれを利用した細胞培養容器および細胞培養方法 | |
JP7368470B2 (ja) | 細胞培養用容器の製造方法 | |
JP2021024860A (ja) | 骨組織関連疾患の予防または治療剤 | |
JP2015213497A (ja) | ポリイミドを表面に含む細胞培養用基材 | |
JP2020094044A (ja) | ヒアルロン酸含有スフェロイド及びその作製方法 | |
JP2020137519A (ja) | ヒト脂肪由来幹細胞スフェロイドの製造方法 | |
US20220145241A1 (en) | Method for producing cell spheroids | |
JP6681665B2 (ja) | 加熱処理によりイミド化された含フッ素ポリイミドを表面に含む細胞培養用基材 | |
JP6870681B2 (ja) | 細胞の調製方法、細胞培養装置及びキット | |
JP2015213496A (ja) | エーテル結合及び/又はチオエーテル結合とフッ素原子とを含むポリイミドを表面に含む細胞培養用基材 | |
JP6901252B2 (ja) | 接着性細胞培養用基材、ならびにこれを利用した細胞培養容器および細胞培養方法 | |
JP2021159082A (ja) | 細胞シートの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19834416 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2020530212 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20207037805 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2019302182 Country of ref document: AU Date of ref document: 20190709 Kind code of ref document: A |